1
|
Shrivastava P, Panda M, Kaitholia K, Dixit S, Kumawat R, Shankar H, Sharma AN, Chaubey G. Haplogroup diversity in the Indian population using 23 Y- STRs. Ann Hum Biol 2022; 49:200-203. [PMID: 35726777 DOI: 10.1080/03014460.2022.2091796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
Abstract
BACKGROUND A Y-STR polymorphism study is a convenient tool in molecular anthropology and forensic DNA analysis. AIM Through standard ethical procedures, the proposed study explored the genetic scenario in male lineage in Madhya Pradesh, a central Indian state, by Y-STR genotyping and haplogroup studies. SUBJECTS AND METHODS 511 unrelated male blood samples were directly amplified, and fragment separation was done using capillary electrophoresis to generate Y-STR profile for 23 forensic relevant markers through PowerPlex® Y 23 multiplex system. The different statistical methods were applied for studying the forensic and genetics parameters. Subsequently, population comparison was performed by AMOVA, PCoA and MDS plot, and Haplogroups were predicted with Whit Athey's haplogroup predictor tool. CONCLUSION These data represented the potential value of the PowerPlex® Y-23 multiplex system for the forensic and human genetics application in the population of Madhya Pradesh, India. Simultaneously the Haplogroup analysis revealed information about the multi-geographic origin as well as multi-ethnic genetic affinities of the Madhya Pradesh population.
Collapse
Affiliation(s)
- Pankaj Shrivastava
- Biological Sciences Division, Regional Forensic Science Laboratory, Department of Home (Police), Govt. of MP, Gwalior-474011, India.,Department of Anthropology, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar- 470003, Madhya Pradesh, India
| | - Muktikanta Panda
- Department of Anthropology, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar- 470003, Madhya Pradesh, India
| | - Kamlesh Kaitholia
- DNA Unit, Regional Forensic Science Laboratory, Department of Home (Police), Govt. of MP, Bhopal-463002, India
| | - Shivani Dixit
- School of Life Sciences, Jaipur National University, Jaipur, Rajasthan
| | - Ramkishan Kumawat
- DNA Division, State Forensic Science Laboratory, Rajasthan, Jaipur -302016, India
| | - Hari Shankar
- DNA Fingerprinting Unit, State Forensic Science Laboratory, Department of Home (Police), Govt. of MP, Sagar-470001, India
| | - A N Sharma
- Department of Anthropology, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar- 470003, Madhya Pradesh, India
| | - Gyaneshwer Chaubey
- Cytogenetics Laboratory, Dept. of Zoology, Banaras Hindu University, Varanasi-221005, India
| |
Collapse
|
2
|
Sharma AN, Kumar S, Tyagi AK. Effects of mannan-oligosaccharides and Lactobacillus acidophilus supplementation on growth performance, nutrient utilization and faecal characteristics in Murrah buffalo calves. J Anim Physiol Anim Nutr (Berl) 2018; 102:679-689. [PMID: 29493022 DOI: 10.1111/jpn.12878] [Citation(s) in RCA: 32] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2017] [Accepted: 01/29/2018] [Indexed: 12/15/2022]
Abstract
A study of 120 days was undertaken to ascertain the effect of mannan-oligosaccharides (MOS) and Lactobacillus acidophilus supplementation on growth performance, nutrient utilization and faecal characteristics in Murrah buffalo calves. Twenty Murrah buffalo calves of 5-7 days old and 31 ± 2.0 kg of body weight (BW) were randomly assigned into four groups. Group I served as the control (CON) in which only basal diet (concentrate mixture and green fodder) was provided, without any supplementation. Mannan-oligosaccharides at 4 g/calf/day were supplemented as prebiotic to Group II (PRE), whereas Group III (PRO) received Lactobacillus acidophilus in the form of fermented milk as probiotic at 200 ml/calf/day having 108 CFU/ml and Group IV (SYN) was supplemented with both MOS and Lactobacillus acidophilus as synbiotic at similar dose. Final BW (kg), dry matter intake, average daily gain, feed conversion efficiency and structural growth measurements were improved (p < .05) in the treatment groups compared to control. Digestibility of neutral detergent fibre was higher (p < .05) in SYN followed by PRE and PRO than control. The faecal lactobacilli and bifidobacterium population was higher (p < .05) in all the supplemented groups with a concomitant reduction in faecal coliform count as compared to control. Faecal ammonia, lactate and pH were also altered favourably (p < .05) in all the supplemented groups as compared to CON. The faecal volatile fatty acids were higher (p < .05) in PRE, PRO and SYN group than CON. The incorporation of MOS and Lactobacillus acidophilus in diet either individually or in combination as synbiotic has the potential to improve the performance and faecal characteristics in Murrah buffalo calves; however, the observed responses among the treatment groups were more evident in the synbiotic fed group compared to individual supplementation of MOS and Lactobacillus acidophilus.
Collapse
Affiliation(s)
- A N Sharma
- Animal Nutrition Division, ICAR-National Dairy Research Institute, Karnal, India
| | - S Kumar
- Animal Nutrition Division, ICAR-National Dairy Research Institute, Karnal, India
| | - A K Tyagi
- Animal Nutrition Division, ICAR-National Dairy Research Institute, Karnal, India
| |
Collapse
|
3
|
Tran LV, Malla BA, Sharma AN, Kumar S, Tyagi N, Tyagi AK. Effect of omega-3 and omega-6 polyunsaturated fatty acid enriched diet on plasma IGF-1 and testosterone concentration, puberty and semen quality in male buffalo. Anim Reprod Sci 2016; 173:63-72. [PMID: 27596261 DOI: 10.1016/j.anireprosci.2016.08.012] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2016] [Revised: 08/26/2016] [Accepted: 08/28/2016] [Indexed: 11/25/2022]
Abstract
The objective of the present study was to evaluate the effect of omega-3 and omega-6 PUFA enriched diet on plasma IGF-1 and testosterone concentrations, puberty, sperm fatty acid profile and semen quality in male buffalo. Eighteen male buffalo calves were distributed randomly in three different groups and fed concentrate mixture along with green fodder and wheat straw in 50:40:10 ratios as per requirements. Basis ration of animals in group I was supplemented with 4% of prilled fat (PFA), while in group II and group III were added 4.67% of Calcium salt from Soybean (CaSFA) and Linseed oil (CaLFA), respectively. Male buffalo fed omega-3 PUFA high diet significantly increased concentrations of IGF-1 and testosterone in plasma as compared to two other diets (p<0.05). The age of puberty and scrotal circumference significantly increased by dietary fat effect (p<0.05) of which n-3 PUFA enriched diet (CaLFA) had the largest influence as compared to other diets (PFA and CaSFA). Feeding of n-3 PUFA rich diet significantly increased the DHA (C22:6n-3) content in sperm (p<0.05), which contributed to increased fluidity of plasma membrane, elevated quality of sperm (motility, viability) and in vitro fertility (plasma membrane integrity, acrosome integrity) in both fresh and post-thawing semen. These findings indicate that feeding of n-3 PUFA enriched diet increased IGF-1 and testosterone secretion, reduced pubertal age and improved both fresh and post-thawing semen quality in male buffalo.
Collapse
Affiliation(s)
- L V Tran
- Animal Nutrition Division, National Dairy Research Insititute, Karnal-132001, Haryana, India
| | - B A Malla
- Animal Nutrition Division, National Dairy Research Insititute, Karnal-132001, Haryana, India
| | - A N Sharma
- Animal Nutrition Division, National Dairy Research Insititute, Karnal-132001, Haryana, India
| | - Sachin Kumar
- Animal Nutrition Division, National Dairy Research Insititute, Karnal-132001, Haryana, India
| | - Nitin Tyagi
- Animal Nutrition Division, National Dairy Research Insititute, Karnal-132001, Haryana, India
| | - A K Tyagi
- Animal Nutrition Division, National Dairy Research Insititute, Karnal-132001, Haryana, India.
| |
Collapse
|
4
|
Blevins CH, Sharma AN, Johnson ML, Geno D, Gupta M, Bharucha AE, Katzka DA, Iyer PG. Influence of reflux and central obesity on intercellular space diameter of esophageal squamous epithelium. United European Gastroenterol J 2015; 4:177-83. [PMID: 27087944 DOI: 10.1177/2050640615598426] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/08/2015] [Accepted: 07/08/2015] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND While central obesity increases gastroesophageal reflux (GER) by mechanically disrupting the anti-reflux barrier, limited data exist on pathways by which central obesity may potentiate esophageal injury by non-mechanical means. Obesity has been associated with an impaired epithelial intestinal barrier. OBJECTIVE We aimed to assess the influence of central obesity and reflux on the squamous esophageal epithelial intercellular space diameter (ICSD). METHODS The ICSD was measured using electron microscopy in esophageal biopsies from individuals who underwent ambulatory pH monitoring and endoscopy. Anthropometric measurements were obtained on all participants. Participants were classified into four groups: with and without central obesity and reflux. RESULTS Sixteen individuals were studied with four in each study group. The mean ICSD was almost three-fold greater (p < 0.001) in the group with central obesity without reflux, compared to controls without central obesity and reflux. It was also comparable to the ICSD in groups with acid reflux only and those with both reflux and central obesity. CONCLUSIONS There is evidence of esophageal squamous ICSD increase in individuals with central obesity who do not have evidence of acid and nonacid reflux on ambulatory pH monitoring. This may reflect a mechanism by which central obesity potentiates reflux-induced esophageal injury and inflammation.
Collapse
Affiliation(s)
- Christopher H Blevins
- Department of Internal Medicine, Mayo Clinic, Rochester, USA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA
| | - Anamay N Sharma
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA
| | - Michele L Johnson
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA
| | - Deborah Geno
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA
| | - Milli Gupta
- Division of Gastroenterology, University of Calgary, Alberta, Canada
| | - Adil E Bharucha
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA
| | - David A Katzka
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA
| | - Prasad G Iyer
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA
| |
Collapse
|
5
|
Chak A, Buttar NS, Foster NR, Seisler DK, Marcon NE, Schoen R, Cruz-Correa MR, Falk GW, Sharma P, Hur C, Katzka DA, Rodriguez LM, Richmond E, Sharma AN, Smyrk TC, Mandrekar SJ, Limburg PJ. Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2015; 13:665-72.e1-4. [PMID: 25218668 PMCID: PMC4362887 DOI: 10.1016/j.cgh.2014.08.040] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/13/2014] [Revised: 08/14/2014] [Accepted: 08/19/2014] [Indexed: 02/07/2023]
Abstract
BACKGROUND & AIMS Obesity is associated with neoplasia, possibly via insulin-mediated cell pathways that affect cell proliferation. Metformin has been proposed to protect against obesity-associated cancers by decreasing serum insulin. We conducted a randomized, double-blind, placebo-controlled, phase 2 study of patients with Barrett's esophagus (BE) to assess the effect of metformin on phosphorylated S6 kinase (pS6K1), a biomarker of insulin pathway activation. METHODS Seventy-four subjects with BE (mean age, 58.7 years; 58 men [78%; 52 with BE >2 cm [70%]) were recruited through 8 participating organizations of the Cancer Prevention Network. Participants were randomly assigned to groups given metformin daily (increasing to 2000 mg/day by week 4, n = 38) or placebo (n = 36) for 12 weeks. Biopsy specimens were collected at baseline and at week 12 via esophagogastroduodenoscopy. We calculated and compared percent changes in median levels of pS6K1 between subjects given metformin vs placebo as the primary end point. RESULTS The percent change in median level of pS6K1 did not differ significantly between groups (1.4% among subjects given metformin vs -14.7% among subjects given placebo; 1-sided P = .80). Metformin was associated with an almost significant reduction in serum levels of insulin (median -4.7% among subjects given metformin vs 23.6% increase among those given placebo, P = .08) as well as in homeostatic model assessments of insulin resistance (median -7.2% among subjects given metformin vs 38% increase among those given placebo, P = .06). Metformin had no effects on cell proliferation (on the basis of assays for KI67) or apoptosis (on the basis of levels of caspase 3). CONCLUSIONS In a chemoprevention trial of patients with BE, daily administration of metformin for 12 weeks, compared with placebo, did not cause major reductions in esophageal levels of pS6K1. Although metformin reduced serum levels of insulin and insulin resistance, it did not discernibly alter epithelial proliferation or apoptosis in esophageal tissues. These findings do not support metformin as a chemopreventive agent for BE-associated carcinogenesis. ClinicalTrials.gov number, NCT01447927.
Collapse
Affiliation(s)
- Amitabh Chak
- Department of Gastroenterology and Hepatology, University Hospitals Case Medical Center, Cleveland, Ohio.
| | | | | | | | | | | | | | - Gary W. Falk
- University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
| | | | - Chin Hur
- Massachusetts General Hospital, Boston, MA
| | | | - Luz M. Rodriguez
- Division of Cancer Prevention, National Cancer Institute, National Institutes of Health
| | - Ellen Richmond
- Division of Cancer Prevention, National Cancer Institute, National Institutes of Health
| | | | | | | | | | | |
Collapse
|
6
|
Singh S, Sharma AN, Murad MH, Buttar NS, El-Serag HB, Katzka DA, Iyer PG. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013; 11:1399-1412.e7. [PMID: 23707461 PMCID: PMC3873801 DOI: 10.1016/j.cgh.2013.05.009] [Citation(s) in RCA: 221] [Impact Index Per Article: 20.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/20/2013] [Revised: 05/07/2013] [Accepted: 05/08/2013] [Indexed: 02/07/2023]
Abstract
BACKGROUND & AIMS Central adiposity has been implicated as a risk factor for Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC), possibly promoting the progression from inflammation to metaplasia and neoplasia. We performed a systematic review and meta-analysis of studies to evaluate the association between central adiposity and erosive esophagitis (EE), BE, and EAC, specifically exploring body mass index (BMI)-independent and gastroesophageal reflux (GERD)-independent effects of central adiposity on the risk of these outcomes. METHODS We performed a systematic search of multiple databases through March 2013. Studies were included if they reported effect of central adiposity (visceral adipose tissue area, waist-hip ratio, and/or waist circumference) on the risk of EE, BE, and EAC. Summary adjusted odds ratio (aOR) estimates with 95% confidence intervals (CIs), comparing highest category of adiposity with the lowest category of adiposity, were calculated by using random-effects model. RESULTS Forty relevant articles were identified. Compared with patients with normal body habitus, patients with central adiposity had a higher risk of EE (19 studies; aOR, 1.87; 95% CI, 1.51-2.31) and BE (17 studies; aOR, 1.98; 95% CI, 1.52-2.57). The association between central adiposity and BE persisted after adjusting for BMI (5 studies; aOR, 1.88; 95% CI, 1.20-2.95). Reflux-independent association of central adiposity and BE was observed in studies that used GERD patients as controls or adjusted for GERD symptoms (11 studies; aOR, 2.04; 95% CI, 1.44-2.90). In 6 studies, central adiposity was associated with higher risk of EAC (aOR, 2.51; 95% CI, 1.54-4.06), compared with normal body habitus. CONCLUSIONS On the basis of a meta-analysis, central adiposity, independent of BMI, is associated with esophageal inflammation (EE), metaplasia (BE), and neoplasia (EAC). Its effects are mediated by reflux-dependent and reflux-independent mechanisms.
Collapse
Affiliation(s)
- Siddharth Singh
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
| | - Anamay N. Sharma
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
| | | | - Navtej S. Buttar
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
| | - Hashem B. El-Serag
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Baylor College of Medicine, Houston, Texas
| | - David A. Katzka
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
| | - Prasad G. Iyer
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
| |
Collapse
|
7
|
Ernst A, Sharma AN, Elased KM, Guest PC, Rahmoune H, Bahn S. Diabetic db/db mice exhibit central nervous system and peripheral molecular alterations as seen in neurological disorders. Transl Psychiatry 2013; 3:e263. [PMID: 23715298 PMCID: PMC3669927 DOI: 10.1038/tp.2013.42] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
The db/db mouse is a widely used preclinical model in diabetes research. Recent studies have shown that these mice also display aspects of psychosis and depression-like behaviors as seen in some psychiatric disorders. Here, we have performed multiplex immunoassay and liquid chromatography mass spectrometry profiling of the plasma and brain samples from db/db and control mice to identify altered pathways, which could be related to these behavioral abnormalities. This is the first study to carry out profiling of the brain proteome in this model. Plasma from the db/db mice had increased levels of leptin and insulin, decreased levels of peptide YY, glucagon and prolactin and alterations in inflammation-related proteins, compared with control mice. Frontal cortex tissue from the db/db mice showed changes in proteins involved in energy metabolism, cellular structure and neural functioning, and the hippocampus had changes in proteins involved in the same pathways, with additional effects on cellular signalling proteins. The overlap of these findings with effects seen in type 2 diabetes, schizophrenia, major depressive disorder and Alzheimer's disease might contribute to a common endophenotype seen in metabolic and neurological disorders.
Collapse
Affiliation(s)
- A Ernst
- Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK
| | - A N Sharma
- Department of Pharmacology and Toxicology, Wright State University, Boonshoft School of Medicine, Dayton, OH, USA
| | - K M Elased
- Department of Pharmacology and Toxicology, Wright State University, Boonshoft School of Medicine, Dayton, OH, USA
| | - P C Guest
- Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK
| | - H Rahmoune
- Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK,Department of Chemical Engineering and Biotechnology, University of Cambridge, Tennis Court Road, Cambridge CB21QT, UK. E-mail: or
| | - S Bahn
- Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK,Department of Neuroscience, Erasmus Medical Centre, Rotterdam, The Netherlands,Department of Chemical Engineering and Biotechnology, University of Cambridge, Tennis Court Road, Cambridge CB21QT, UK. E-mail: or
| |
Collapse
|
8
|
Abstract
OBJECTIVE To analyze the incidence and severity of cardiovascular disease in patients with Williams syndrome (WS) and to identify factors contributing to its variable expression. METHODS Clinical data on patients with WS were collected from several WS centers. Elastin gene deletions were confirmed in all patients. Age at diagnosis, growth data, and cardiovascular diagnoses were recorded retrospectively. Cardiac diagnoses were made on the basis of echocardiographic data. The severity of supravalvular aortic stenosis was recorded by using a 4-step scale (none, mild, moderate, severe). RESULTS Statistical analysis of the data revealed that the severity of both supravalvular aortic stenosis and total cardiovascular disease was significantly greater in male patients than female patients (P <.002 and P <.002, respectively; Kruskal-Wallis rank-sum test). This difference was not accounted for by differences in height, weight, body mass index, or head circumference. The clinical diagnosis of WS was made at a significantly younger age in male patients (P <.01, Student t test). Earlier diagnosis was partly because of increased incidence and severity of cardiovascular disease. Another determinant of early diagnosis was low body mass index. CONCLUSION Penetrance and severity of the elastin arteriopathy in patients with WS is affected by sex. We hypothesize that differences by sex in arterial stenoses may be related to prenatal hormonal effects. Future epidemiologic and in vitro studies may provide additional insight into the pathogenetic mechanisms of these observed differences.
Collapse
Affiliation(s)
- L S Sadler
- Division of Genetics, Children's Hospital of Buffalo, New York, USA
| | | | | | | | | | | | | |
Collapse
|
9
|
|
10
|
|
11
|
Sharma AN, Steinberg K, Nelson LS. Akathisia and prochlorperazine. Ann Emerg Med 2000; 36:169-170. [PMID: 10918114 DOI: 10.1067/mem.2000.108179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
12
|
Nazziola E, Sharma AN, Hoffman RS. Sedation and analgesia for procedures in children. N Engl J Med 2000; 343:302-3. [PMID: 10928883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
|
13
|
Goyal A, Sharma AN, Sharma DN, Sharma RD. Sinus histiocytosis with massive lymphadenopathy. J Indian Med Assoc 1983; 80:28-9. [PMID: 6875270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
14
|
Sharma PN, Sharma AN. Cytochemical characteristics of the neurosecretory cells of Ceylonocotyle scoliocoelium (Trematoda: Digenea). J Helminthol 1981; 55:223-9. [PMID: 7276507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
Two types of neurosecretory cells (NSC), large alpha cells and small beta cells were detected on the basis of their size and characteristics as shown by aldehyde fuchsin and chrome haematoxylin-phloxin staining. A histochemical survey of the neurosecretory material indicates that it is a glycoprotein. Phosphatases and esterases present in NSC probably help in the transfer of metabolites and their hydrolysis and in the control of secretory material produced in a NSC, while SDH provides the necessary energy for the synthetic activity of the latter. The role of neurosecretion in governing the reproduction of this parasite is discussed.
Collapse
|
15
|
Dixit VP, Jain HC, Sharma AN, Bhargava SK, Sandhu JS. Effects of cyproterone acetate on the testicular function of bat (Rhinopoma kinneari Wroughton). Indian J Physiol Pharmacol 1978; 22:82-6. [PMID: 680942] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
1-Cyproterone acetate administration (0.2 mg/day/animal for 25 days) caused widespread testicular necrosis. The lumen of the epididymides were devoid of spermatozoa. The RNA, protein, sialic acid and phosphatase enzyme activity of the testes were reduced. Serum transaminase enzyme activity was slightly changed. Haemoglobin, hematocrit, blood sugar, and blood urea levels were in the normal range. Regressed Leydig cell tissue and decreased production of RNA and sialic acid in the testes could be due to the antiandrogenic action produced by cyproterone acetate.
Collapse
|
16
|
Dixit VP, Jain HC, Verma OP, Sharma AN. Effects of cannabis extract on the testicular function of the toad Bufo andersonii Boulenger. Indian J Exp Biol 1977; 15:555-7. [PMID: 598898] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
17
|
Sharma RD, Bansal RD, Sharma AN. Pathogenic intestinal parasites in New Kangra District, Himachal Pradesh. J Indian Med Assoc 1975; 64:255-8. [PMID: 1176779] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
18
|
Sharma AN, Soroff HS, Bellas AE, Sachs BF, Nettleblad SC, Deterling RA. Experimental studies of the homotransplantation of pulmonary tissue. Surg Gynecol Obstet 1966; 123:1001-9. [PMID: 5332803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
19
|
Sharma AN, Soroff HS, Bellas AE, Giron F, Deterling RA. Physiologic studies following reimplantation and homotransplantation of pulmonary lobes and the effect of dibenzyline on the incidence of vascular thrombosis. J Thorac Cardiovasc Surg 1966; 52:635-48. [PMID: 5333749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
20
|
Sharma AN, Soroff HS, Bellas AE, Harrison HN, Sherman J, Deterling RA. Experimental studies of the autotransplantation of pulmonary tissue. Surg Gynecol Obstet 1966; 123:295-302. [PMID: 5330488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
21
|
|
22
|
Sharma AN, Sardana DS. Stellate ganglion block in Bell's Palsy. Eye Ear Nose Throat Mon 1965; 44:84-5 passim. [PMID: 5831259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|